Has Rebecca Kazin received payments from drug or device companies?

Yes. Drug and device makers reported $342,003 in general payments to Rebecca Kazin across 225 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rebecca Kazin did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rebecca Kazin come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rebecca Kazin

Dermatology · Chevy Chase, MDNPI 1588619878

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $231,265 of the $342,003 with a category attached, or 67.6%. Galderma Laboratories, L.p. accounts for 77.3% of it on its own, with 7 other manufacturers making up the rest. Among dermatology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$342,003in general payments, 2019–2025

Across 225 payments — averaging $1520.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$264K
AbbVie$75K
Merz North America, Inc.$2K
Solta Medical, A Division Of Bausch Health US, LLC$182
Revance Therapeutics, Inc.$181
Endo Pharmaceuticals Inc.$164
plus $50 from 2 others

$1,388,914in research payments, 2019–2025

Across 47 payments — averaging $29,551 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$1.4M

What the payments were for

Consulting fees$97,56029%
Speaking & faculty fees$231,26568%
Travel & lodging$9,0923%
Food & beverage$4,0861%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	122	$264,295
AbbVie(2 entities)	67	$75,253
Merz North America, Inc.	25	$1,878
Solta Medical, A Division Of Bausch Health US, LLC	1	$182
Revance Therapeutics, Inc.	5	$181
Endo Pharmaceuticals Inc.	2	$164
Organon	2	$31
Almirall LLC	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$342,003 in reported general payments places this provider in the 95th percentile of 306 dermatology providers in Maryland.

See all dermatology providers in Maryland →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Minoxidil	15	$288

Paid to pharmacies, not to this prescriber.

Other dermatology in Chevy Chase

Alison EhrlichChevy Chase$163K
Pantea TamjidiChevy Chase$100K
Gary PeckChevy Chase$14K
Mana OgholikhanChevy Chase$13K
Benjamin LockshinSilver Spring$4M
Shawn KwatraBaltimore$1.1M
Chesahna Kindred WeaverMarriottsville$837K
Oanh LauringNottingham$763K
Ronald PrussickN Bethesda$620K
Susan WalkerBethesda$221K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →